Study on Long-Term Safety of Secukinumab for Patients with Polymyalgia Rheumatica
- Substances:Secukinumab
Spain- Participants:18–64 years · 65+ years
- Substances:Secukinumab
- Sponsor:Novartis Pharma AG
Rare diseases
Investigational molecules
Locations
Back to Spain3 147 clinical trials in Barcelona, Spain across 23 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SpainEnsayosClinicos.es(opens in a new tab)
SpainStudy of Pertuzumab and Trastuzumab for Patients with Solid Malignant Tumors from Previous Pertuzumab Trials
SpainStudy on the Effects and Safety of Riliprubart for Patients with Chronic Inflammatory Demyelinating Polyneuropathy Unresponsive to Usual Treatments
SpainStudy of SKB264 for Patients with Advanced Solid Tumors Not Responding to Standard Treatments
SpainStudy on Reduced Dose of Alteplase for Patients with Intermediate-High-Risk Acute Pulmonary Embolism
SpainStudy on Sotorasib for Patients with Unresectable Stage III Non-Small Cell Lung Cancer with KRAS Mutation
SpainStudy on the Effects of Selpercatinib in Children with Advanced RET-Altered Solid Tumors or Primary Central Nervous System Tumors
SpainStudy on Long-term Safety of Seralutinib for Patients with Pulmonary Arterial Hypertension
SpainStudy Comparing Savolitinib and Durvalumab with Sunitinib and Durvalumab for Patients with Advanced Papillary Renal Cell Carcinoma
SpainStudy Comparing Lorlatinib and Crizotinib for Patients with Advanced ALK-Positive Non-Small Cell Lung Cancer
SpainStudy on the Long-term Safety and Efficacy of Ralinepag for Patients with Pulmonary Arterial Hypertension
SpainStudy Comparing Datopotamab Deruxtecan to Chemotherapy in Patients with Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer
SpainThe busiest research cities in the country
What the registry says about research in the country
Innovative studies focusing on Alzheimer's Disease and Frontotemporal Dementia, utilizing advanced brain imaging techniques to track disease progression and evaluate new therapeutic approaches.
Advanced neuroimaging studies using PET tracers to understand disease mechanisms.
Comprehensive vaccine trials targeting various infections including Respiratory Syncytial Virus, Cytomegalovirus, and Herpes Zoster.
Focus on developing effective immunization strategies for vulnerable populations.
Research examining treatments for Type 1 Diabetes and obesity, alongside studies in bladder cancer and urinary tract infections.
Innovative approaches to chronic disease management and prevention.
Tell us about your condition – we search every trial in Europe and connect you with the right site.